R & D SYSTEMS search R & D Systems IGF1 products
includes other brands or spellings
|
| block | | R & D Systems monoclonal anti-human IGF-I antibody was used in human Kaposi's sarcoma cells (KS cells) and in blocking expriments to study the molecular mechanisms through which HIV-1-Tat protein inhibits vincristine-induced apoptosis of KS cells. |
| block | | R&D Systems neutralizing human IGF-1 antibody was used in blocking or activating expriments to study matrix metalloproteinase-13 expression in human chondrocytes. |
| elisa | | R&D Systems IGF-1 matched pairs of monoclonal capture and biotinylated detector Abs were used in ELISA to identify selective basophil chemoattractants in human nasal polyps. |
SANTA CRUZ BIOTECHNOLOGY search Santa Cruz Biotechnology IGF1 products
includes other brands or spellings
|
| ip, wb | | Santa Cruz anti-IGF-IR antibody was used in western blot and immunoprecipitation to study cells with mutant IGF-I receptor at tyrosines 1250 and 1251. |
DIAGNOSTIC SYSTEMS LABORATORIES
|
| ih | | Diagnostic Systems Laboratories IGF-I antibody was used in immunohistochemistry to study PAPP-A expression in healing human skin. |
DIAGNOSTIC SYSTEMS LABORATORY
|
| elisa | | Diagnostic Systems Laboratory IGF1 ELISA kits were used to study the total and free IGF1 levels in serums from healthy women, in women suffering from breast cancer, and in women with benign breast disease. |
Articles Reviewed |
| 1. Maria Chiara Deregibus et al. HIV-1-Tat protein activates phosphatidylinositol 3-kinase/ AKT-dependent survival pathways in Kaposi's sarcoma cells. 2002 |
| 2. Hee-Jeong Im et al. Inhibitory effects of insulin-like growth factor-1 and osteogenic protein-1 on fibronectin fragment- and interleukin-1beta-stimulated matrix metalloproteinase-13 expression in human chondrocytes. 2003 |
| 3. Bing-Kun Chen et al. Localization and regulation of pregnancy-associated plasma protein a expression in healing human skin. 2003 |
| 4. Christian F Singer et al. Insulin-like growth factor (IGF)-I and IGF-II serum concentrations in patients with benign and malignant breast lesions: free IGF-II is correlated with breast cancer size. 2004 |
| 5. Adele Hartnell et al. Identification of selective basophil chemoattractants in human nasal polyps as insulin-like growth factor-1 and insulin-like growth factor-2. 2004 |
| 6. Patrick A Kiely et al. RACK1-mediated integration of adhesion and insulin-like growth factor I (IGF-I) signaling and cell migration are defective in cells expressing an IGF-I receptor mutated at tyrosines 1250 and 1251. 2005 |